Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen A Fairman

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Journal of Managed Care Pharmacy : JMCP|February 25, 2010
Interpreting hazards: the increasing importance of "antidote to anecdote" in managed careKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|November 14, 2008
Accuracy in pharmacoeconomic literature review: lessons learned from the Navajo Code TalkersKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|August 4, 2007
Differentiating effective data mining from fishing, trapping, and cruelty to numbersKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
Peeking inside the statistical black box: how to analyze quantitative information and get it right the first timeKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|May 3, 2012
10 tips for a great health care research articleKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|March 26, 2011
Why hypotheses informed by observation are often wrong: results of randomized controlled trials challenge chronic disease management strategies based on epidemiological evidenceKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The future of prescription drug cost-sharing: real progress or dropped opportunity?Kathleen A Fairman
The American Journal of Managed Care|September 10, 2008
Utilization outcomes and patient cost sharingKathleen A Fairman
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2021
Modest Association of Long-Term ACE Inhibitor Treatment With Lung Cancer: The Promise and Pitfalls of Epidemiological Drug-Safety AnalysesKathleen A Fairman
Annals of Epidemiology|March 1, 2022
Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution?Kathleen A Fairman
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Managed Care Pharmacy : JMCP|February 25, 2010
Interpreting hazards: the increasing importance of "antidote to anecdote" in managed careKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|November 14, 2008
Accuracy in pharmacoeconomic literature review: lessons learned from the Navajo Code TalkersKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|August 4, 2007
Differentiating effective data mining from fishing, trapping, and cruelty to numbersKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
Peeking inside the statistical black box: how to analyze quantitative information and get it right the first timeKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|May 3, 2012
10 tips for a great health care research articleKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|March 26, 2011
Why hypotheses informed by observation are often wrong: results of randomized controlled trials challenge chronic disease management strategies based on epidemiological evidenceKathleen A Fairman
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The future of prescription drug cost-sharing: real progress or dropped opportunity?Kathleen A Fairman
The American Journal of Managed Care|September 10, 2008
Utilization outcomes and patient cost sharingKathleen A Fairman
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2021
Modest Association of Long-Term ACE Inhibitor Treatment With Lung Cancer: The Promise and Pitfalls of Epidemiological Drug-Safety AnalysesKathleen A Fairman
Annals of Epidemiology|March 1, 2022
Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution?Kathleen A Fairman
Pageof 9